Literature DB >> 19179436

Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract during morphine withdrawal.

Cristina Núñez1, Anna Földes, Domingo Pérez-Flores, J Carlos García-Borrón, M Luisa Laorden, Krisztina J Kovács, M Victoria Milanés.   

Abstract

Chronic opiate exposure induces neurochemical adaptations in the noradrenergic system. Enhanced responsiveness of the hypothalamo-pituitary-adrenal axis after morphine withdrawal has been associated with hyperactivity of ascending noradrenergic input from the nucleus of the solitary tract (NTS-A(2)) cell group to the hypothalamic paraventricular nucleus (PVN). This study addressed the role of morphine withdrawal-induced corticosterone (CORT) release in regulation of tyrosine hydroxylase (TH), the rate-limiting enzyme of catecholamine biosynthesis in adrenalectomized (ADX) rats supplemented with low CORT pellet (ADX plus CORT). Present results show that in sham-ADX rats, noradrenergic neurons in the NTS-A(2) became activated during morphine withdrawal, as indicated by increased TH mRNA expression. However, this induction of TH expression is not detected in ADX plus CORT rats that are unable to mount CORT secretory response to morphine withdrawal. Total TH protein levels were elevated in the NTS-A(2) from sham-operated rats during morphine dependence and withdrawal, whereas we did not find any alteration in ADX plus CORT animals. Furthermore, high levels of TH phosphorylated (activated) at Ser31 (but not at Ser40) were found in the A(2) area from sham-morphine withdrawn rats. Consistent with these effects, we observed an increase in the enzyme activity of TH in the PVN. However, induction of morphine withdrawal to ADX plus CORT animals did not alter the phosphorylation (activation) of TH in NTS-A(2) and decreased TH activity in the PVN. These results suggest the existence of a positive reverberating circle in which elevated glucocorticoids during morphine abstinence play a permissive role in morphine withdrawal-induced activation of noradrenergic pathway innervating the PVN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19179436      PMCID: PMC2703550          DOI: 10.1210/en.2008-1732

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  49 in total

1.  Effects of stress and adrenalectomy on tyrosine hydroxylase mRNA levels in the locus ceruleus by in situ hybridization.

Authors:  M A Smith; L S Brady; J Glowa; P W Gold; M Herkenham
Journal:  Brain Res       Date:  1991-03-22       Impact factor: 3.252

2.  Regulation of tyrosine hydroxylase and phenylethanolamine N-methyltransferase mRNA levels in the sympathoadrenal system by the pituitary-adrenocortical axis.

Authors:  M K Stachowiak; R J Rigual; P H Lee; O H Viveros; J S Hong
Journal:  Brain Res       Date:  1988-06       Impact factor: 3.252

3.  Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system.

Authors:  K R Melia; R S Duman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

Review 4.  Intricate regulation of tyrosine hydroxylase activity and gene expression.

Authors:  S C Kumer; K E Vrana
Journal:  J Neurochem       Date:  1996-08       Impact factor: 5.372

5.  Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.

Authors:  H N Bhargava; A Gulati; P Ramarao
Journal:  J Pharmacol Exp Ther       Date:  1989-10       Impact factor: 4.030

6.  Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies.

Authors:  A L Curtis; D E Grigoriadis; M E Page; J Rivier; R J Valentino
Journal:  J Pharmacol Exp Ther       Date:  1994-01       Impact factor: 4.030

7.  Multiple signaling pathways in bovine chromaffin cells regulate tyrosine hydroxylase phosphorylation at Ser19, Ser31, and Ser40.

Authors:  J W Haycock
Journal:  Neurochem Res       Date:  1993-01       Impact factor: 3.996

8.  Regulation of extracellular signal-regulated kinases (ERKs) by naloxone-induced morphine withdrawal in the brain stress system.

Authors:  Cristina Núñez; M Teresa Castells; M Luisa Laorden; M Victoria Milanés
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-12       Impact factor: 3.000

9.  Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus.

Authors:  E T Cunningham; P E Sawchenko
Journal:  J Comp Neurol       Date:  1988-08-01       Impact factor: 3.215

Review 10.  Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: in vivo microdialysis studies.

Authors:  K Pacak; M Palkovits; I J Kopin; D S Goldstein
Journal:  Front Neuroendocrinol       Date:  1995-04       Impact factor: 8.606

View more
  18 in total

1.  CRF₂ mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats.

Authors:  Javier Navarro-Zaragoza; Cristina Núñez; Jessica Ruiz-Medina; M Luisa Laorden; Olga Valverde; M Victoria Milanés
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

Review 2.  Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions.

Authors:  Linda Rinaman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-10-20       Impact factor: 3.619

3.  Effect of chronic intermittent hypoxia on noradrenergic activation of hypoglossal motoneurons.

Authors:  Georg M Stettner; Victor B Fenik; Leszek Kubin
Journal:  J Appl Physiol (1985)       Date:  2011-10-20

4.  Glucocorticoid receptors participate in the opiate withdrawal-induced stimulation of rats NTS noradrenergic activity and in the somatic signs of morphine withdrawal.

Authors:  Javier Navarro-Zaragoza; Juana M Hidalgo; M Luisa Laorden; M Victoria Milanés
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

5.  Morphine withdrawal stress modulates lipopolysaccharide-induced interleukin 12 p40 (IL-12p40) expression by activating extracellular signal-regulated kinase 1/2, which is further potentiated by glucocorticoids.

Authors:  Subhas Das; Jennifer Kelschenbach; Richard Charboneau; Roderick A Barke; Sabita Roy
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

6.  Protein kinase C phosphorylates the cAMP response element binding protein in the hypothalamic paraventricular nucleus during morphine withdrawal.

Authors:  F Martín; L Mora; Ml Laorden; Mv Milanés
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

7.  Morphine administration modulates expression of Argonaute 2 and dopamine-related transcription factors involved in midbrain dopaminergic neurons function.

Authors:  D García-Pérez; F Sáez-Belmonte; M L Laorden; C Núñez; M V Milanés
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

8.  Elevated corticosterone in the dorsal hindbrain increases plasma norepinephrine and neuropeptide Y, and recruits a vasopressin response to stress.

Authors:  Daisy L Daubert; Benjamin M Looney; Rebekah R Clifton; Jake N Cho; Deborah A Scheuer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-05-14       Impact factor: 3.619

9.  Role of corticotropin-releasing factor (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc).

Authors:  Pilar Almela; Javier Navarro-Zaragoza; Juan-Antonio García-Carmona; Lucía Mora; Juana Hidalgo; María-Victoria Milanés; María-Luisa Laorden
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

10.  Effect of berberine on depression- and anxiety-like behaviors and activation of the noradrenergic system induced by development of morphine dependence in rats.

Authors:  Bombi Lee; Bongjun Sur; Mijung Yeom; Insop Shim; Hyejung Lee; Dae-Hyun Hahm
Journal:  Korean J Physiol Pharmacol       Date:  2012-12-10       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.